- recruitingPHASE3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
This study is testing a new treatment called anti-COVID-19 immunoglobulin (hIVIG) for adults recently diagnosed with COVID-19 who don't need hospital care. Researchers want to see if hIVIG is safe and effective in preventing severe illness compared to a dummy treatment (placebo).
United States · Argentina · Australia - active not recruiting
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
This study looks at how people who had severe COVID-19 and were in intensive care are doing one year later. Researchers want to understand their physical health, mental wellbeing, and how it affects their daily lives, including getting back to work.
France